Company Jaguar Health Inc Nasdaq
Equities
US47008L1061
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Health
98.2
%
| 12 | 98.2 % | 10 | 98.2 % | -18.34% |
Animal Health
1.8
%
| 0 | 1.8 % | 0 | 1.8 % | -19.53% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 12 | 100.0 % | 10 | 100.0 % | -18.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 05/06/13 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 30/04/19 |
Chief Tech/Sci/R&D Officer | 60 | 30/04/17 | |
Jonathan Wolin
CMP | Compliance Officer | 62 | 31/10/18 |
Chief Tech/Sci/R&D Officer | 62 | 30/04/21 | |
Peter C. Hodge
IRC | Investor Relations Contact | - | - |
Karen Brunke
PRN | Corporate Officer/Principal | 72 | 08/09/21 |
Ian Wendt
PRN | Corporate Officer/Principal | - | - |
David Sesin
PRN | Corporate Officer/Principal | - | - |
Steven King
PRN | Corporate Officer/Principal | 66 | 31/12/03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 05/06/13 |
James Bochnowski
CHM | Chairman | 80 | 31/01/14 |
John Micek
BRD | Director/Board Member | 71 | 31/03/16 |
Jonathan Siegel
BRD | Director/Board Member | 50 | 28/03/18 |
Director/Board Member | 67 | 30/06/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 9 | 0 | 0 | 92.16 % |
Stock B | 1 | 276,216,260 | 254,562,311 ( 92.16 %) | 0 |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.46% | 21.25B | |
-5.94% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |